Suchergebnisse - "Hui, David S C"

PubPharm (288)

1

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT+ BA.4/5) bivalent booster vaccination

enthalten in: ResearchSquare.com | 2024

von Cheng, S. | Mok, C. | Li, J. | +16

2

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination

enthalten in: Virology journal | 2024

von Cheng, S. | Mok, C. | Li, J. | +16

3

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination

enthalten in: Virology journal | 2024

von Cheng, S. | Mok, C. | Li, J. | +16

4

Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong

enthalten in: Emerging infectious diseases | 2024

von Zhao, S. | Mok, C. | Tang, Y. | +4

5

Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2024

von Cheng, S. | Lau, J. | Tsang, L. | +17

6

Author Correction : Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

enthalten in: Nature medicine | 2024

von Lau, J. | Cheng, S. | Leung, K. | +17

ErratumFor: Nat Med. 2023 Feb;29(2):348-357. - PMID 36652990

7

Oseltamivir May or May Not Reduce Hospitalizations

enthalten in: JAMA internal medicine | 2024

von Uyeki, T. | Hui, D. | Lee, N.

8

Defining infection transmission pathways for future pandemic preparedness - An urgent public health research priority

enthalten in: The Journal of infection | 2023

von Pan, D. | Hui, D. | Tang, J.

9

Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines

enthalten in: Signal transduction and targeted therapy | 2023

von Peng, Y. | Zhang, L. | Mok, C. | +19

10

Use of point-of-care biomarkers to reduce antibiotic resistance

enthalten in: The Lancet. Infectious diseases | 2023

von Hui, D.

CommentOn: Lancet Infect Dis. 2023 Sep;23(9):1085-1094. - PMID 37230105

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]